Sunshine Biopharma Inc.

11/15/2011 | Press release | Archived content

SUNSHINE BIOPHARMA’S ANNOUNCES SUCCESSFUL COMPLETION OF PRECLINICAL STUDIES FOR ADVA 27A, THE COMPANY’S LEAD ANTI CANCER COMPOUND